FDA authorization to begin first clinical trial

# FDA authorization to begin first clinical trial **Entity class:** Program or project **Collections:** [[collections/Neurotech|Neurotech]] · [[collections/Consciousness Continuity|Consciousness Continuity]] ## Definition **FDA authorization to begin first clinical trial** is a program or project. [[wiki/Motif Neurotech|Motif Neurotech]] is associated with **FDA authorization to begin first clinical trial**. 2026-04-28 Rice report; not commercial approval. The entry centers on the program's stated purpose, participants, methods, timetable, and results, distinguishing announced aims from completed work and later applications. ## Relationships  This entry is routed through [[collections/Neurotech|Neurotech]] and [[collections/Consciousness Continuity|Consciousness Continuity]]. Its source context is developed in [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]], [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]], [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]], and [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]]. Status-qualified source edges are preserved in the terminal Research Edges section. ### Governance, authority, and safeguards - [[wiki/Motif Neurotech|Motif Neurotech]] is associated with **FDA authorization to begin first clinical trial**. 2026-04-28 Rice report; not commercial approval.  ## Research Edges  #### Consciousness mapping and transfer graph patch — 2026-09-10 **Collections:** [[collections/Neurotech|Neurotech]] · [[collections/Consciousness Continuity|Consciousness Continuity]] **Relationship source:** [[research/Consciousness Mapping and Transfer Ecosystem Relationship Graph - 2026-09-10|Consciousness Mapping and Transfer Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] · [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] #### Incoming typed edges - **Edge 176 — [[wiki/Motif Neurotech|Motif Neurotech]] `regulatory_milestone` → this entry** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_TRIAL_2026`. 2026-04-28 Rice report; not commercial approval.